|
In the 2004 insider survey, some Big Pharmas lost ground while fast-moving biotechs shot to the top.
Feb 1, 2005
By:
Doretta W. Gasorek, Jeffrey T. Resnick
As a reputation driver, ethical behavior has increased steadily in importance over the last three years.
|
In a second Annual PE exclusive, Rating Research ranks companies on their Leadership, competitiveness, ethics, and more.
Jun 1, 2003
By:
Jeffrey T. Resnick
Even among industry insiders, company reputations are hard-earned and subject to change. Rating Research's (RRC) second annual Reputation Strength Study of the Pharmaceutical Industry surveyed financial analysts and industry senior executives to see how 19 companies stack up against each other and to see how their overall reputations changed from last year.
|
|
A new survey of pharma companies evaluates leading and lagging players-and identifies potential stars.
Jun 1, 2002
By:
Jeffrey T. Resnick
From Washington, DC, to company boardrooms to business schools, the debacle that led to the down-fall of Enron and Arthur Anderson has spawned a flurry of activity.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
